MedPath

Evaluation of soft tissue and bone height changes around calcium-phosphate coated and uncoated implants

Completed
Conditions
Disorder of gingiva and edentulousalveolar ridge, unspecified,
Registration Number
CTRI/2022/06/043193
Lead Sponsor
kota sindhu
Brief Summary

The procedure will be performed under local anesthesia using 2% lignocaine containing  adrenaline 1:80,000.

Implants will be placed by following surgical procedure in both the groups.

After adequate local anesthesia, a mid-crestal incision is given in both the cases.A mucoperiosteal flap is elevated and bone will be exposed.

The implant site will be prepared with standard drills. The osteotomy site is prepared with sequence of drills to the size of implant.

Sites in group I will be treated with placement of calcium-phosphate coated implants and sites in group II will be treated with placement of uncoated implants.

After placement, stability is checked by RFA at baseline.

Cover screw will be given following the implant placement in both groups. Flaps will be approximated and sutured. Instructions regarding oral hygiene maintenance and soft diet plan will be provided. Patient will be discharged after prescribing analgesics and antibiotics.Patient is recalled after 1 week for suture removal.Crown placement will be done after 3 months.Clinical parameters like thickness of keratinized tissue,modified plaque index,width of keratinized tissue and crestal bone level(by IOPA radiographs) will be assessed at baseline,3 months and 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 1.Individuals with age group of 20-60 years.2.Apparently healthy individuals.
  • 3.Individuals in need of tooth replacement.
  • 4.Isolated mandibular edentulous sites with adequate bone quality (D2 or D3 type) and volume.
  • 5.Presence of adequate keratinized tissue at the edentulous site.6.Patients who are willing to give informed consent.
Exclusion Criteria
  • 1.Smokers.2.Individuals with parafunctional habits.3.Pregnant and lactating women.
  • 4.Systemic diseases that contraindicate implant placement and surgical procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate soft tissue and crestal bone levels around calcium-phosphate coated implants.baseline,3months,6months
2.To evaluate soft tissue and crestal bone levels around uncoated implants.baseline,3months,6months
Secondary Outcome Measures
NameTimeMethod
3.To compare soft tissue and crestal bone levels between calcium-phosphate coated and uncoated implants.baseline,3months,6months

Trial Locations

Locations (1)

Sibar Institute of Dental Sciences

🇮🇳

Guntur, ANDHRA PRADESH, India

Sibar Institute of Dental Sciences
🇮🇳Guntur, ANDHRA PRADESH, India
Kota Sindhu
Principal investigator
9866889394
kotasindhu1718@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.